VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy

M. Tempero, Margaret Anne Kessinger, H. M. Lemon

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.

Original languageEnglish (US)
Pages (from-to)155-157
Number of pages3
JournalCancer Clinical Trials
Volume4
Issue number2
StatePublished - Dec 1 1981

Fingerprint

Small Cell Lung Carcinoma
Etoposide
Combination Drug Therapy
Leukopenia
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy. / Tempero, M.; Kessinger, Margaret Anne; Lemon, H. M.

In: Cancer Clinical Trials, Vol. 4, No. 2, 01.12.1981, p. 155-157.

Research output: Contribution to journalArticle

Tempero, M. ; Kessinger, Margaret Anne ; Lemon, H. M. / VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy. In: Cancer Clinical Trials. 1981 ; Vol. 4, No. 2. pp. 155-157.
@article{22205b5fd70b476eb966fff4b8e875d7,
title = "VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy",
abstract = "Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.",
author = "M. Tempero and Kessinger, {Margaret Anne} and Lemon, {H. M.}",
year = "1981",
month = "12",
day = "1",
language = "English (US)",
volume = "4",
pages = "155--157",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy

AU - Tempero, M.

AU - Kessinger, Margaret Anne

AU - Lemon, H. M.

PY - 1981/12/1

Y1 - 1981/12/1

N2 - Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.

AB - Twenty-two patients with small-cell carcinoma of the lung who had failed combination chemotherapy were treated with VP-16-213 as a single agent. A partial remission was achieved in one patient. Twenty-three percent of the patients experienced arrest of disease for a median of 31 weeks. Leukopenia was a major complicating side effect.

UR - http://www.scopus.com/inward/record.url?scp=0019830848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019830848&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 155

EP - 157

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 2

ER -